NCT04332133View on ClinicalTrials.gov

Outcomes of Subthreshold Laser Versus Intravitreal Injection of Ranibizumab in Diabetic Macular Edema

NACompletedINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

December 31, 2016

Primary Completion Date

March 31, 2019

Study Completion Date

December 31, 2019

Conditions
Diabetic Macular Edema
Interventions
PROCEDURE

laser interference,INTRAVITREAL INJECTION

sub threshold micro pulse laser for DME for group 1 and intravitreal injection of Ranibizumab for group 2

All Listed Sponsors
lead

Minia University

OTHER

NCT04332133 - Outcomes of Subthreshold Laser Versus Intravitreal Injection of Ranibizumab in Diabetic Macular Edema | Biotech Hunter | Biotech Hunter